The third quarter report of Express Scripts Holding Company (NYSE:ESRX) was discussed in which it was discovered the revenues were down at 3.2% year over year in the quarter report to about $25.9 billion which surpassed the Zacks Consensus Estimate which was of $25.0 billion. The decrease in the revenue was a result of the lower claims volume which was owing to the transition of the claims of United Health Care Group.
The adjusted gross profit discovered in the third quarter report was down from 3.4% to $2.1 billion. Moreover, the adjusted selling, administrative and other general expenses also declined by 17.2% to $510.8 million. The total adjusted claims of Express Scripts Holding Company came out to be $358.1 million which was down by 9% due to the expected roll off of the claims from the United Health Care Group.
The total cash generated from the operating activities was $1.0 billion which is only 31% year over year. Also Express Scripts Holding Company repurchased 11.6 million shares for around $751.5 million. Out of these shares repurchased 51.3 million shares are still lying under the current share repurchase program of the company. The company is now expecting adjusted earnings in the range of $4.30 to $4.34.
With the help of recent reports made available, the shares of Express Scripts Holding Company have fallen down on a rapid rate. The shares fallen down was after the market rose slightly and the pharmacy manager reported a 9 percent rise in the third quarter earnings.
The St. Louis market, The Spark said that after the market closed, the company earned around $426.7 million or around 52 cents per share when the third quarter ended in September. This is much more as compared to the net income earned last year which was nearly $391.4 million.
